Debiopharm, an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective...
Israeli startup Sanolla, which provides AI-powered primary care diagnostic solutions, announced that the FDA has granted 510(k) clearance for the clinical use of the...
Kuleana Technology, Inc. (Kuleana), a Seattle Washington-based company, received the National Kidney Foundation (NKF) Innovation Fund's first dialysis investment. Kuleana is developing a groundbreaking...
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics to benefit people with rare metabolic diseases, shared additional...
